029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
DCH1001胆囊癌及边缘组织组合芯片,附病理分级、TNM和临床分期,50例/100点
点 数100例 数50
行 数10列 数10
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:DCH1001
 
胆囊癌及边缘组织组合微阵列芯片,包含33例腺癌,6例腺鳞癌,4例鳞状细胞癌,2例小细胞癌,5例边缘组织,一例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Gal
-Gallbladder
 
Malignant (IIA)
 
Malignant (IIIA)
 
Malignant (IIIB)
 
Malignant (IVA)
 
Malignant (IVB)
 
NAT (*)
TISSUE  ARRAYS DCH1001
1
2
3
4
5
6
7
8
9
10
A
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
B
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
C
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
D
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
E
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
F
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
G
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
H
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
I
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
J
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
GAL
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1175FGallbladderAdenocarcinoma1--2T3N1M0IIIBMalignant5.0N
A2275FGallbladderAdenocarcinoma1--2T3N1M0IIIBMalignant5.0N
A3351FGallbladderPapillary adenocarcinoma1--2T3N0M0IIIAMalignant5.0N
A4451FGallbladderPapillary adenocarcinoma1--2T3N0M0IIIAMalignant5.0N
A5545FGallbladderAdenocarcinoma2T3N1M0IIIBMalignant*N
A6645FGallbladderAdenocarcinoma2T3N1M0IIIBMalignant*N
A7735FGallbladderAdenocarcinoma2T3N0M0IIIAMalignant4.0N
A8835FGallbladderAdenocarcinoma2T3N0M0IIIAMalignant4.0N
A9964FGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
A101064FGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
B11156MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
B21256MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
B31371MGallbladderAdenocarcinoma (sparse)2T3N2M0IVBMalignant6.0N
B41471MGallbladderAdenocarcinoma (sparse)2T3N2M0IVBMalignant6.0N
B51564FGallbladderAdenocarcinoma2T3N0M0IIIAMalignant6.5N
B61664FGallbladderAdenocarcinoma2T3N0M0IIIAMalignant6.5N
B71775MGallbladderAdenocarcinoma2T3N2M0IVBMalignant4.0N
B81875MGallbladderAdenocarcinoma2T3N2M0IVBMalignant4.0N
B91973MGallbladderAdenocarcinoma (sparse)2T3N2M0IVBMalignant7.0N
B102073MGallbladderAdenocarcinoma (interstitial)2T3N2M0IVBMalignant7.0N
C12145MGallbladderAdenocarcinoma2T3N1M0IIIBMalignant3.0N
C22245MGallbladderAdenocarcinoma2T3N1M0IIIBMalignant3.0N
C32384FGallbladderAdenocarcinoma2T3N1M0IIIBMalignant3.0N
C42484FGallbladderAdenocarcinoma2T3N1M0IIIBMalignant3.0N
C52556MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant6.0N
C62656MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant6.0N
C72746MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant7.5N
C82846MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant7.5N
C92954MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
C103054MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
D13168MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant4*5N
D23268MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant4*5N
D33331MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
D43431MGallbladderAdenocarcinoma2T3N0M0IIIAMalignant5.0N
D53556FGallbladderAdenocarcinoma2T2aN0M0IIAMalignant5.5N
D63656FGallbladderAdenocarcinoma2T2aN0M0IIAMalignant5.5N
D73751MGallbladderAdenocarcinoma (interstitial)2T3N0M0IIIAMalignant5.0N
D83851MGallbladderAdenocarcinoma (interstitial)2T3N0M0IIIAMalignant5.0N
D93976FGallbladderAdenocarcinoma2T3N1M0IIIBMalignant5.0N
D104076FGallbladderAdenocarcinoma2T3N1M0IIIBMalignant5.0N
E14175MGallbladderAdenocarcinoma2T3N2M0IVBMalignant6.0N
E24275MGallbladderAdenocarcinoma2T3N2M0IVBMalignant6.0N
E34361MGallbladderAdenocarcinoma with necrosis2T2N1M0IIIBMalignant*N
E44461MGallbladderAdenocarcinoma2T2N1M0IIIBMalignant*N
E54569FGallbladderAdenocarcinoma (sparse)2--3T3N1M0IIIBMalignant5.0N
E64669FGallbladderAdenocarcinoma with necrosis (sparse)2--3T3N1M0IIIBMalignant5.0N
E74778FGallbladderAdenocarcinoma2--3T3N0M0IIIAMalignant*N
E84878FGallbladderAdenocarcinoma2--3T3N0M0IIIAMalignant*N
E94958MGallbladderAdenocarcinoma3T3N1M0IIIBMalignant5.0N
E105058MGallbladderAdenocarcinoma3T3N1M0IIIBMalignant5.0N
F15161FGallbladderAdenocarcinoma3T3N1M0IIIBMalignant5.0N
F25261FGallbladderAdenocarcinoma3T3N1M0IIIBMalignant5.0N
F35378FGallbladderAdenocarcinoma3T4N2M0IVBMalignant7.0N
F45478FGallbladderAdenocarcinoma3T4N2M0IVBMalignant7.0N
F55556FGallbladderAdenocarcinoma3T4N2M0IVBMalignant8.0N
F65656FGallbladderAdenocarcinoma3T4N2M0IVBMalignant8.0N
F75760MGallbladderAdenocarcinoma3T3N0M0IIIAMalignant6.0N
F85860MGallbladderAdenocarcinoma3T3N0M0IIIAMalignant6.0N
F95942FGallbladderAdenocarcinoma3T3N0M0IIIAMalignant6.0N
F106042FGallbladderAdenocarcinoma3T3N0M0IIIAMalignant6.0N
G16156FGallbladderAdenocarcinoma3T3N2M0IVBMalignant5.0N
G26256FGallbladderAdenocarcinoma3T3N2M0IVBMalignant5.0N
G36371MGallbladderAdenocarcinoma with necrosis3T3N2M0IVBMalignant4.0N
G46471MGallbladderAdenocarcinoma3T3N2M0IVBMalignant4.0N
G56560MGallbladderAdenocarcinoma3T3N1M0IIIBMalignant6.0N
G66660MGallbladderAdenocarcinoma3T3N1M0IIIBMalignant6.0N
G76773FGallbladderAdenosquamous carcinoma*T3N2M0IVBMalignant5.0N
G86873FGallbladderAdenosquamous carcinoma*T3N2M0IVBMalignant5.0N
G96956FGallbladderAdenosquamous carcinoma*T3N1M0IIIBMalignant7*7*4N
G107056FGallbladderAdenosquamous carcinoma*T3N1M0IIIBMalignant7*7*4N
H17167MGallbladderAdenosquamous carcinoma*T4N1M0IVAMalignant3*2N
H27267MGallbladderAdenosquamous carcinoma*T4N1M0IVAMalignant3*2N
H37359FGallbladderAdenosquamous carcinoma*T3N2M0IVBMalignant4.0N
H47459FGallbladderAdenosquamous carcinoma*T3N2M0IVBMalignant4.0N
H57572MGallbladderAdenosquamous carcinoma3T3N2M0IVBMalignant5.0N
H67672MGallbladderAdenosquamous carcinoma3T3N2M0IVBMalignant5.0N
H77748FGallbladderAdenosquamous carcinoma3T3N0M0IIIAMalignant*N
H87848FGallbladderAdenosquamous carcinoma3T3N0M0IIIAMalignant*N
H97969MGallbladderSquamous cell carcinoma with necrosis2T3N1M0IIIBMalignant5.0N
H108069MGallbladderSquamous cell carcinoma with necrosis2T3N1M0IIIBMalignant5.0N
I18175FGallbladderSquamous cell carcinoma2T3N2M0IVBMalignant4.0N
I28275FGallbladderSquamous cell carcinoma2T3N2M0IVBMalignant4.0N
I38353FGallbladderSquamous cell carcinoma2T3N0M0IIIAMalignant6.0N
I48453FGallbladderSquamous cell carcinoma2T3N0M0IIIAMalignant6.0N
I58559MGallbladderSquamous cell carcinoma2T3N0M0IIIAMalignant*N
I68659MGallbladderSquamous cell carcinoma2T3N0M0IIIAMalignant*N
I78772FGallbladderSmall cell carcinoma*T3N0M0IIIAMalignant4*5N
I88872FGallbladderSmall cell carcinoma*T3N0M0IIIAMalignant4*5N
I98941MGallbladderSmall cell carcinoma with necrosis*T3N0M0IIIAMalignant7.0N
I109041MGallbladderSmall cell carcinoma*T3N0M0IIIAMalignant7.0N
J19153FGallbladderAdjacent normal gallbladder tissue***NAT*N
J29253FGallbladderAdjacent normal gallbladder tissue***NAT*N
J39363FGallbladderAdjacent normal gallbladder tissue***NAT*N
J49463FGallbladderAdjacent normal gallbladder tissue***NAT*N
J59561MGallbladderAdjacent normal gallbladder tissue***NAT*N
J69661MGallbladderAdjacent normal gallbladder tissue***NAT*N
J79752FGallbladderAdjacent normal gallbladder tissue***NAT*N
J89852FGallbladderAdjacent normal gallbladder tissue***NAT*N
J99972MGallbladderAdjacent normal gallbladder tissue***NAT*N
J1010072MGallbladderAdjacent normal gallbladder tissue***NAT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情